Group Therapy Program + Phentermine-Topiramate for psychotic disorders

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 9 Oct 2025: Trial registered, NCT07213466
  2. 19 Jan 2026: Trial started, NCT07213466

The trials

NCT07213466: Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder

State
Under way
Phase
Phase 4
People
100 planned
Started
19 Jan 2026
Primary completion
1 Feb 2028
Arms
Phentermine/Topiramate (Qsymia) + Group Therapy Program
Results
None posted
  1. 9 Oct 2025: Trial registered
  2. 19 Jan 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.